These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
113 related articles for article (PubMed ID: 1351044)
1. An attempt to define sets of cooperating genetic alterations in human breast cancer. Cheickh MB; Rouanet P; Louason G; Jeanteur P; Theillet C Int J Cancer; 1992 Jun; 51(4):542-7. PubMed ID: 1351044 [TBL] [Abstract][Full Text] [Related]
2. Genetic alterations of the tumour suppressor gene regions 3p, 11p, 13q, 17p, and 17q in human breast carcinomas. Andersen TI; Gaustad A; Ottestad L; Farrants GW; Nesland JM; Tveit KM; Børresen AL Genes Chromosomes Cancer; 1992 Mar; 4(2):113-21. PubMed ID: 1373310 [TBL] [Abstract][Full Text] [Related]
3. 11q13 amplification in local recurrence of human primary breast cancer. Champème MH; Bièche I; Lizard S; Lidereau R Genes Chromosomes Cancer; 1995 Feb; 12(2):128-33. PubMed ID: 7535085 [TBL] [Abstract][Full Text] [Related]
4. Patterns of allele losses suggest the existence of five distinct regions of LOH on chromosome 17 in breast cancer. Kirchweger R; Zeillinger R; Schneeberger C; Speiser P; Louason G; Theillet C Int J Cancer; 1994 Jan; 56(2):193-9. PubMed ID: 8314300 [TBL] [Abstract][Full Text] [Related]
5. Somatic mutations and human breast cancer. A status report. Callahan R; Cropp CS; Merlo GR; Liscia DS; Cappa AP; Lidereau R Cancer; 1992 Mar; 69(6 Suppl):1582-8. PubMed ID: 1540899 [TBL] [Abstract][Full Text] [Related]
6. Loss of heterozygosity on chromosomes 17 and 18 in breast carcinoma: two additional regions identified. Cropp CS; Lidereau R; Campbell G; Champene MH; Callahan R Proc Natl Acad Sci U S A; 1990 Oct; 87(19):7737-41. PubMed ID: 1977164 [TBL] [Abstract][Full Text] [Related]
7. Allelotype of human breast carcinoma: a second major site for loss of heterozygosity is on chromosome 6q. Devilee P; van Vliet M; van Sloun P; Kuipers Dijkshoorn N; Hermans J; Pearson PL; Cornelisse CJ Oncogene; 1991 Sep; 6(9):1705-11. PubMed ID: 1681492 [TBL] [Abstract][Full Text] [Related]
8. Analysis of genetic alterations related to the development and progression of breast carcinoma. Nagayama K; Watatani M Jpn J Cancer Res; 1993 Nov; 84(11):1159-64. PubMed ID: 7903963 [TBL] [Abstract][Full Text] [Related]
9. Frequent loss of heterozygosity at the DCC locus in gastric cancer. Uchino S; Tsuda H; Noguchi M; Yokota J; Terada M; Saito T; Kobayashi M; Sugimura T; Hirohashi S Cancer Res; 1992 Jun; 52(11):3099-102. PubMed ID: 1591722 [TBL] [Abstract][Full Text] [Related]
10. Correlation of loss of alleles on the short arms of chromosomes 11 and 17 with metastasis of primary breast cancer to lymph nodes. Takita K; Sato T; Miyagi M; Watatani M; Akiyama F; Sakamoto G; Kasumi F; Abe R; Nakamura Y Cancer Res; 1992 Jul; 52(14):3914-7. PubMed ID: 1617666 [TBL] [Abstract][Full Text] [Related]
11. At least four different chromosomal regions are involved in loss of heterozygosity in human breast carcinoma. Devilee P; van den Broek M; Kuipers-Dijkshoorn N; Kolluri R; Khan PM; Pearson PL; Cornelisse CJ Genomics; 1989 Oct; 5(3):554-60. PubMed ID: 2575586 [TBL] [Abstract][Full Text] [Related]
12. Molecular genetic changes in human epithelial ovarian malignancies. Gallion HH; Powell DE; Morrow JK; Pieretti M; Case E; Turker MS; DePriest PD; Hunter JE; van Nagell JR Gynecol Oncol; 1992 Nov; 47(2):137-42. PubMed ID: 1468689 [TBL] [Abstract][Full Text] [Related]
13. Accumulated allelic losses in the development of invasive urothelial cancer. Habuchi T; Ogawa O; Kakehi Y; Ogura K; Koshiba M; Hamazaki S; Takahashi R; Sugiyama T; Yoshida O Int J Cancer; 1993 Feb; 53(4):579-84. PubMed ID: 8094713 [TBL] [Abstract][Full Text] [Related]
14. Genetic progression, histological grade, and allelic loss in ductal carcinoma in situ of the breast. Fujii H; Szumel R; Marsh C; Zhou W; Gabrielson E Cancer Res; 1996 Nov; 56(22):5260-5. PubMed ID: 8912866 [TBL] [Abstract][Full Text] [Related]
15. Mapping of DNA amplifications at 15 chromosomal localizations in 1875 breast tumors: definition of phenotypic groups. Courjal F; Cuny M; Simony-Lafontaine J; Louason G; Speiser P; Zeillinger R; Rodriguez C; Theillet C Cancer Res; 1997 Oct; 57(19):4360-7. PubMed ID: 9331099 [TBL] [Abstract][Full Text] [Related]
16. Chromosome 8p alterations in sporadic and BRCA2 999del5 linked breast cancer. Sigbjörnsdottir BI; Ragnarsson G; Agnarsson BA; Huiping C; Barkardottir RB; Egilsson V; Ingvarsson S J Med Genet; 2000 May; 37(5):342-7. PubMed ID: 10807692 [TBL] [Abstract][Full Text] [Related]
17. Loss of heterozygosity on chromosome 17p13 in breast carcinomas identifies tumors with high proliferation index. Merlo GR; Venesio T; Bernardi A; Canale L; Gaglia P; Lauro D; Cappa AP; Callahan R; Liscia DS Am J Pathol; 1992 Jan; 140(1):215-23. PubMed ID: 1731526 [TBL] [Abstract][Full Text] [Related]
18. Genomic alterations in cervical carcinoma: losses of chromosome heterozygosity and human papilloma virus tumor status. Mullokandov MR; Kholodilov NG; Atkin NB; Burk RD; Johnson AB; Klinger HP Cancer Res; 1996 Jan; 56(1):197-205. PubMed ID: 8548763 [TBL] [Abstract][Full Text] [Related]
19. Accumulation of genetic alterations and progression of primary breast cancer. Sato T; Akiyama F; Sakamoto G; Kasumi F; Nakamura Y Cancer Res; 1991 Nov; 51(21):5794-9. PubMed ID: 1682035 [TBL] [Abstract][Full Text] [Related]
20. [Genetic alterations in localized cancers of the prostate: identification of a common region of deletion on the chromosome 18q]. Latil A; Baron JC; Cussenot O; Fournier G; Soussi T; Boccon-Gibod L; Le Duc A; Rouëssé J; Lidereau R Bull Cancer; 1995 Jul; 82(7):589-97. PubMed ID: 7549122 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]